Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stability and uniqueness of clonal immunoglobulin CDR3 sequences for MRD tracking in multiple myeloma
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 94, Issue 12, Pages 1364-1373
Publisher
Wiley
Online
2019-10-01
DOI
10.1002/ajh.25641
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Commonality despite exceptional diversity in the baseline human antibody repertoire
- (2019) Bryan Briney et al. NATURE
- Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
- (2019) Even H. Rustad et al. PLoS One
- High frequency of shared clonotypes in human B cell receptor repertoires
- (2019) Cinque Soto et al. NATURE
- The Immune Landscape of Cancer
- (2018) Vésteinn Thorsson et al. IMMUNITY
- Immunoglobulin gene analysis as a tool for investigating human immune responses
- (2018) Deborah Dunn-Walters et al. IMMUNOLOGICAL REVIEWS
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Minimal residual disease detection of myeloma using sequencing of immunoglobulin heavy chain gene VDJ regions
- (2018) Caleb Ho et al. SEMINARS IN HEMATOLOGY
- MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical Tool
- (2018) Ola Landgren SEMINARS IN HEMATOLOGY
- Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding
- (2018) Sara D’Angelo et al. Frontiers in Immunology
- Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
- (2018) Aurore Perrot et al. BLOOD
- Establishment of Immunoglobulin Heavy Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms
- (2018) Maria E. Arcila et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Monitoring multiple myeloma by quantification of recurrent mutations in serum
- (2017) Even Holth Rustad et al. HAEMATOLOGICA
- Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
- (2017) Anna Oberle et al. HAEMATOLOGICA
- Antigen receptor repertoire profiling from RNA-seq data
- (2017) Dmitriy A Bolotin et al. NATURE BIOTECHNOLOGY
- Monitoring multiple myeloma by quantification of recurrent mutations in serum
- (2017) Even Holth Rustad et al. HAEMATOLOGICA
- Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
- (2017) Anna Oberle et al. HAEMATOLOGICA
- Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
- (2017) Nikhil C. Munshi et al. JAMA Oncology
- Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V’DJer
- (2016) Lisle E. Mose et al. BIOINFORMATICS
- Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma
- (2016) N. Weinhold et al. BLOOD
- Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis
- (2016) O Landgren et al. BONE MARROW TRANSPLANTATION
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The predominant myeloma clone at diagnosis, CDR3 defined, is constantly detectable across all stages of disease evolution
- (2015) N Puig et al. LEUKEMIA
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma
- (2015) Graeme Cowan et al. Oncotarget
- VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
- (2015) Mikhail Shugay et al. PLoS Computational Biology
- Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
- (2015) Neha Korde et al. JAMA Oncology
- Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
- (2014) Jens G. Lohr et al. CANCER CELL
- Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
- (2014) Niccolo Bolli et al. Nature Communications
- Using synthetic templates to design an unbiased multiplex PCR assay
- (2013) Christopher S. Carlson et al. Nature Communications
- Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
- (2012) J. B. Egan et al. BLOOD
- Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
- (2012) M. Faham et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search